Affinivax
GSK Shifts Focus from Acquired Vaccine to Preclinical Successor Due to Increased Competition
GSK, vaccine, preclinical successor, increased competition, pneumococcal vaccine, Affinivax, MAPS technology
Actionable Insights Powered by AI
GSK, vaccine, preclinical successor, increased competition, pneumococcal vaccine, Affinivax, MAPS technology